RxDoctor Payments Data

Holly Hamil, DO

Family Medicine · Oak Ridge, TNNPI 1679007439

Payments from drug & device makers

$537in general payments, 2019–2025

Across 36 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$204
  • Novo Nordisk$50
  • GSK$37
  • Merck$36
  • Sanofi-aventis U.S. LLC$31
  • Bayer$30
  • plus $150 from 9 others

What the payments were for

  • Food & beverage$537100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$537 in reported general payments places this provider in the 50th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$99,500
Medicare patients
252
Services billed
1,968

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide105$136,990
OzempicSemaglutide71$104,274
JardianceEmpagliflozin60$79,478
Trelegy ElliptaFluticasone/Umeclidin/Vilanter83$78,911
FarxigaDapagliflozin Propanediol51$54,085
EliquisApixaban59$51,524
Repatha SureclickEvolocumab24$18,544
TrulicityDulaglutide11$18,206
LinzessLinaclotide16$17,031
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$16,479
Soliqua 100-33Insulin Glargine/Lixisenatide19$15,717
Breo ElliptaFluticasone/Vilanterol25$15,162
MyrbetriqMirabegron11$13,905
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$12,339
Tresiba Flextouch U-100Insulin Degludec14$9,351

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$24$155,195116 claims
Novo NordiskOzempic$50$104,27471 claims
GSKTrelegy Ellipta, Breo Ellipta$37$94,073108 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$13$74,59093 claims
AbbVieLinzess$204$17,03116 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$31$15,71719 claims
Astellas Pharma US IncMyrbetriq$20$13,90511 claims
MerckJanuvia$36$6,43812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Oak Ridge

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →